Joseph J. Prorok

Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement

Mark C. Plucinsky, W. Michael Riley, Joseph J. Prorok et al. · Cancer · 1986 · 109 citations · Full text

Lipid-associated Sialic Acid, Carbohydrate Aberrations, Malignant Disease +12

Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer

Gary T. Verazin, Michael W. Riley, John Gregory et al. · Diseases of the Colon & Rectum · 1990 · 32 citations

Surgical Oncology, Gastroenterology, Pathology +17

Variant serum β-hexosaminidase as a biochemical marker of malignancy

Mark C. Plucinsky, Joseph J. Prorok, Jack A. Alhadeff · Cancer · 1986 · 15 citations · Full text

Pathology, Hepatobiliary Tumor, Serum Beta-hexosaminidase +16

Atypical beta-hexosaminidase in sera of cancer patients with liver metastases.

Jack A. Alhadeff, Joseph J. Prorok, Paul A. Dura et al. · PubMed · 1984 · 13 citations

Immunology, Pathology, Atypical Beta-hexosaminidase +17

Improved Procedure for Determination of Serum Lipid-Associated Sialic Acid: Application for Early Diagnosis of Colorectal Cancer

C Tăutu, Gary T. Verazin, Joseph J. Prorok et al. · JNCI Journal of the National Cancer Institute · 1988 · 13 citations

Lipid Analysis, Early Diagnosis, Oncology +15